UK markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
30.46+0.07 (+0.23%)
At close: 4:00PM EST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
2,920,600
3,071,000
3,066,800
2,889,000
Cost of revenue
1,480,500
1,470,300
1,573,800
1,493,900
Gross profit
1,440,100
1,600,700
1,493,000
1,395,100
Operating expenses
Research development
281,600
270,100
246,600
251,700
Selling general and administrative
808,400
760,200
735,200
779,800
Total operating expenses
1,337,600
1,230,700
1,179,200
1,252,700
Operating income or loss
102,500
370,000
313,800
142,400
Interest expense
108,100
78,900
29,600
-
Total other income/expenses net
-352,600
-212,900
-170,100
-375,000
Income before tax
-358,200
78,200
114,100
-232,600
Income tax expense
-111,400
10,300
27,600
78,100
Income from continuing operations
-246,800
67,900
86,500
-310,700
Net income
-246,800
67,900
86,500
-310,700
Net income available to common shareholders
-246,800
67,900
86,500
-378,900
Basic EPS
-
0.18
0.28
-1.06
Diluted EPS
-
0.18
0.28
-1.06
Basic average shares
-
369,000
313,700
356,200
Diluted average shares
-
370,300
313,700
356,200
EBITDA
-
471,600
439,700
460,800